Nepal Approves SII’s ‘Covishield’ For Emergency Use Against Covid-19

Nepal Approves SII’s ‘Covishield’ For Emergency Use Against Covid-19

Jan. 16, 2021, 3:32 p.m.

Nepal Government has approved ‘Covishield’ vaccines manufactured by Serum Institute of India for emergency use against Covid-19 in Nepal.

The Department of Drug Administration (DDA) took the decision on usage of the vaccine which has already received an approval in India.

DDA had called for vaccine manufacturers to register their products for usage in Nepal.

The Serum Institute of India had tied up with AstraZeneca to manufacture COVISHIELD, which was originally developed by a team of scientists at the University of Oxford.

More on Health

The Latest

Latest Magazine

VOL. 15, No. 01, July 16, 2021 (Shrawan 1, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 20, July 2, 2021 (Asadh 18, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 19, June 18, 2021 (Asadh 4, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 18, June 04, 2021 (Jestha 21, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75